A first case report presented a patient with psoriasis and psoriatic arthritis with long-term treatment with infliximab (a chimeric mouse–human monoclonal antibody that inhibits TNF-α), who developed chronic allergic contact dermatitis of the hands, confirmed by a skin biopsy and multiple sensitizations to various contact haptens. The gene discussed is TNF; the disease is psoriatic arthritis.